Additive impact of pre-liver transplant metabolic factors on survival post-liver transplant

Leon A. Adams, Oscar Arauz, Peter W. Angus, Marie Sinclair, Graeme A. Macdonald, Utti Chelvaratnam, Alan J. Wigg, Sze Yeap, Nicholas Shackel, Linda Lin, Spiro Raftopoulos, Geoffrey W. Mccaughan, Gary P. Jeffrey, Australian New Zealand Liver Transplant Study Group

    Research output: Contribution to journalArticlepeer-review

    14 Citations (Scopus)

    Abstract

    Background and Aim: Diabetes at time of liver transplantation is associated with reduced post-transplant survival. We aimed to assess whether additional metabolic conditions such as obesity or hypertension had additive prognostic impact on post-transplantation survival.

    Methods:: A multi-center cohort study of 617 adult subjects undergoing liver transplantation between 2003 and 2009 has been used. Dry body mass index was calculated following adjustment for ascites.

    Results:: After a median follow-up of 5.8years (range 0-10.5), 112 (18.2%) patients died. Diabetes was associated with reduced post-transplant survival (hazard ratio 1.89, 95% confidence interval [CI] 1.25-2.86, P=0.003), whereas obesity, hypertension, dyslipidemia, and the metabolic syndrome itself were not (P>0.3 for all). Patients with concomitant diabetes and obesity had lower survival (adjusted Hazard Ratio [aHR] 2.40, 95%CI 1.32-4.38, P=0.004), whereas obese non-diabetic patients or diabetic non-obese patients had similar survival compared with non-diabetic, non-obese individuals. The presence of hypertension or dyslipidemia did not impact on survival in patients with diabetes (P>0.1 for both). Obese diabetic patients had longer intensive care and hospital stays than non-obese diabetic or obese, non-diabetic patients (P<0.05). The impact of concomitant obesity and diabetes on survival was greater in subjects aged 50+years (52.6% 5-year survival, aHR 3.04, 95% CI 1.54-5.98) or those transplanted with hepatocellular carcinoma (34.1% 5-year survival, aHR 3.35, 95% CI 1.31-5.57). Diabetes without obesity was not associated with an increased mortality rate in these sub-groups.

    Conclusions:: Concomitant diabetes and obesity but not each condition in the absence of the other is associated with reduced post-liver transplant survival. The impact of diabetes and obesity is greater in older patients and those with hepatocellular carcinoma.

    Original languageEnglish
    Pages (from-to)1016-1024
    Number of pages9
    JournalJournal of Gastroenterology and Hepatology (Australia)
    Volume31
    Issue number5
    DOIs
    Publication statusPublished - 1 May 2016

    Keywords

    • Diabetes
    • Liver transplantation
    • Obesity

    Fingerprint Dive into the research topics of 'Additive impact of pre-liver transplant metabolic factors on survival post-liver transplant'. Together they form a unique fingerprint.

    Cite this